Pharmaceutical Companies Are Spending Big Money on Weight-Loss Drug Lobbying

Pharmaceutical Companies Are Spending Big Money on Weight-Loss Drug Lobbying

Semaglutide (GLP-1) weight-loss drug Wegovy, made by pharmaceutical company Novo Nordisk. James Manning/EMPPL PA Wire via APPharmaceutical companies spent big money late last year lobbying the federal government on weight-loss drugs as scrutiny around the price of GLP-1 medications increased, according to new lobbying disclosures reviewed by NOTUS.Companies such as Ozempic and Wegovy manufacturer Novo Nordisk and Mounjaro manufacturer Eli Lilly …